Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 81   

Articles published

ARNA 4.52
price chart
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Sees Large Outflow of ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) managed to eke out gains of 1.65% in intraday trade. The share price increased by 0.07 points to $4.3.
Arena Pharmaceuticals Announces the Departure of Chief Financial Officer  MarketWatch
Zacks Short Term Rating on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is a hold, according to the latest average broker rating of 2.5. The number of analysts in this rating is 6. Research Analysts at Zacks has the shares a rating of 3, which implies that the firms recommendation ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Brokerage Rating Update
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has been handed a rating of 2.5 on a consensus basis by Zacks Research. Using a simplified 1 to 5 scale where 5 represents a Strong Sell and 1 a Strong Buy, 4 analysts polled by Zacks had their ratings ...
Arena Pharmaceuticals, Inc. Analyst Rating Update  Insider Trading Report
Stock Insights: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)  Vanguard Tribune
Arena Pharmaceuticals, Inc. Price Target Update
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The mean estimate for the short term price target for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stands at $5.63 according to 4 Analysts. The higher price target estimate for the stock has been calculated at $8 ...
Biotech Stocks with Optimistic Trend - Arena Pharmaceuticals, Inc. (NASDAQ ...
Mr. Hoffman is expected to remain in his current role at Arena until July 10, 2015. “Robert has been a valuable member of our management team and, on behalf of myself and the company, I thank him for his years of leadership and service to Arena,” said ...
Morning Alert: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Gilead Sciences ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is 2.54%. On last trading day company shares ended up $4.44.
Early Day Buzz: Centene Corp. (NYSE:CNC), Nokia Corporation (ADR) (NYSE ...  Property Mentor
Company Shares of Arena Pharmaceuticals, Inc. Rally 11.08%
Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) rose by 11.08% in the past week and 2.83% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 11.86% and the outperformance increases to 3.97% for the last 4 weeks.
Arena - Belviq Advertising Report For June (ARNA)
Arena (NASDAQ:ARNA) investors have had a tough second quarter. Script sales of the anti-obesity drug Belviq ... The company supplies data on ads aired, networks, spending, and even allow comparisons within a sector. Savvy investors can look at ad data ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock Rating Update
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has been issued a 2.5 rating by the sell-side brokerage firms covering the stock.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Analyst Rating Update
Research firm Zacks has rated Arena Pharmaceuticals (NASDAQ:ARNA) and has ranked it at 3, indicating that for the short term the shares are a hold.